BRAF and pleomorphic xanthoastrocytoma: One cell line derived from NF1-PA (JHH-NF1-PA1) and another from BRAF V600E anaplastic PXA (JHH-PXA1) patients exhibited growth sufficient for preclinical testing in vitro.